Life Sciences VC Firm Seroba Closes $134M Fund
Seroba, a European life sciences venture capital firm, said Thursday it has closed a new fund focused on early-stage life sciences companies at €123 million ($134 million)....To view the full article, register now.
Already a subscriber? Click here to view full article